|Muraglitazar||Muramic Acid||Muramyl Dipeptide||Murexide||Murexine|
|Systematic (IUPAC) name|
|9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl] oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid|
|Licence data||US FDA:|
|Pregnancy cat.||B (US)|
|Legal status||Rx Only (US)|
|Half-life||20 to 40 minutes|
|Mol. mass||500.622 g/mol|
|(what is this?)|
Mupirocin (Bactroban or Centany) is an antibiotic of the monoxycarbolic acid class. It was originally isolated from Pseudomonas fluorescens NCIMB 10586, developed by Beecham.
Mupirocin is bacteriostatic at low concentrations and bactericidal at high concentrations. It is used topically and is effective against Gram-positive bacteria, including MRSA. Mupirocin is a mixture of several pseudomonic acids, with pseudomonic acid A (PA-A) constituting greater than 90% of the mixture. Also present in mupirocin are pseudomonic acid B with an additional hydroxyl group at C8, pseudomonic acid C with a double bond between C10 and C11, instead of the epoxide of PA-A, and pseudomonic acid D with a double bond at C4` and C5` in the 9-hydroxy-nonanoic acid portion of mupirocin.